Skip to content
← Full study record

NCT03389347 · MORE INFO

Limitations, agreements, and source contact

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia · Source last updated 2026-05-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ddima@fredhutch.org
organization
Fred Hutch Cancer Center
phone
206 667-5000
title
Danai Dima
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ddima@fredhutch.org
organization
Fred Hutch Cancer Center
phone
206 667-5000
title
Danai Dima

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice